These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9578011)

  • 1. Effect of renal impairment on the pharmacokinetics and tolerability of tiagabine.
    Cato A; Gustavson LE; Qian J; El-Shourbagy T; Kelly EA
    Epilepsia; 1998 Jan; 39(1):43-7. PubMed ID: 9578011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function.
    Lau AH; Gustavson LE; Sperelakis R; Lam NP; El-Shourbagy T; Qian JX; Layden T
    Epilepsia; 1997 Apr; 38(4):445-51. PubMed ID: 9118850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses.
    Gustavson LE; Mengel HB
    Epilepsia; 1995 Jun; 36(6):605-11. PubMed ID: 7555975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.
    Samara EE; Gustavson LE; El-Shourbagy T; Locke C; Granneman GR; Sommerville KW
    Epilepsia; 1998 Aug; 39(8):868-73. PubMed ID: 9701378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tiagabine monotherapy on abilities, adjustment, and mood.
    Dodrill CB; Arnett JL; Shu V; Pixton GC; Lenz GT; Sommerville KW
    Epilepsia; 1998 Jan; 39(1):33-42. PubMed ID: 9578010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiagabine.
    Schachter SC
    Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiagabine monotherapy in the treatment of partial epilepsy.
    Schachter SC
    Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy.
    Snel S; Jansen JA; Mengel HB; Richens A; Larsen S
    J Clin Pharmacol; 1997 Nov; 37(11):1015-20. PubMed ID: 9505994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiagabine (gabitril) experience in children.
    Pellock JM
    Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs.
    So EL; Wolff D; Graves NM; Leppik IE; Cascino GD; Pixton GC; Gustavson LE
    Epilepsy Res; 1995 Nov; 22(3):221-6. PubMed ID: 8991789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice.
    Łuszczki J; Swiader M; Czuczwar M; Kiś J; Czuczwar SJ
    Pharmacol Biochem Behav; 2003 May; 75(2):319-27. PubMed ID: 12873622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
    Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
    Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of tiagabine in epileptic patients on monotherapy.
    Ingwersen SH; Pedersen PC; Groes L; Nielsen KK; Aarons L
    Eur J Pharm Sci; 2000 Sep; 11(3):247-54. PubMed ID: 11042231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiagabine in clinical practice.
    Genton P; Guerrini R; Perucca E
    Epilepsia; 2001; 42 Suppl 3():42-5. PubMed ID: 11520322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures in a pediatric patient with a tiagabine overdose.
    Kazzi ZN; Jones CC; Morgan BW
    J Med Toxicol; 2006 Dec; 2(4):160-2. PubMed ID: 18072137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiagabine pharmacology in profile.
    Brodie MJ
    Epilepsia; 1995; 36 Suppl 6():S7-S9. PubMed ID: 8595791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety of tiagabine.
    Kälviäinen R
    Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of controlled trials of gabitril (tiagabine): a clinician's viewpoint.
    Loiseau P
    Epilepsia; 1999; 40 Suppl 9():S14-9. PubMed ID: 10612357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves.
    Luszczki JJ
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):483-92. PubMed ID: 18566800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.